36 Chapter 3 of radiation-induced cardiac complications for all patients. Proper selection of patients who benefit most is of the utmost importance. In the Netherlands, the socalled model-based approach will be used to select patients that will benefit most from proton therapy in terms of late toxicity [13]. For this purpose, multivariable prediction models are urgently needed. At present, with an increasing number of long term survivors, awareness of the risk of radiation-induced cardiac morbidity and mortality, by radiation oncologists and cardiologist is of major importance; radiation oncologists as they make the tradeoffs for treatment decisions regarding the balance between toxicity risks and dose distributions on critical organs and should consider to refer patients for preventive programs and cardiologists who must realize that cure rates for esophageal cancer are rising and that these patients have increased risks for cardiac morbidity.
RkJQdWJsaXNoZXIy MTk4NDMw